ulcerative colitis
Conditions
Interventions
evaluation of vascular scoring by colonoscopy
Sponsors
Saitama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who will be able to be examined by colonoscopy Patients who has informed consent
Exclusion criteria
Exclusion criteria: Patients who will not be able to be examined by colonoscopy Patient in pregnant and lactate state Patients who has not informed consent Patients who has or has been treated malignancy Patients with colectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation with vascular scoring and stool calprotectin concentration Correlation with vascular scoring and relapse rate in one year | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation with vascular scoring and stool hemoglobin concentration Correlation with Baron scores and stool hemoglobin or calprotectin concentration Correlation with UCEIS and stool hemoglobin or calprotectin concentration Correlation with mayo score and stool hemoglobin or calprotectin concentration | — |
Countries
Japan
Contacts
Public ContactShingo Kato
Saitama Medical Center Gastroenterology and hepatology
Outcome results
None listed